Allan C. Silber

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Toronto, Ontario, Canada
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ William L. Demers, by Power of Attorney for Allan C. Silber
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Allan C. Silber

Form 4 holding 10%+ Owner

Heritage Global Inc.

Security class
Common Stock
Shares / value
3,198,296
Estimated value
$9,115,144
Report date
02 Sep 2021
Price
$2.85
Ownership
Anglian Holdings, LLC
Form 4 holding 10%+ Owner

Heritage Global Inc.

Security class
Common Stock
Shares / value
374,697
Estimated value
$1,067,886
Report date
01 Sep 2021
Price
$2.85
Ownership
Direct
Form 4 holding 10%+ Owner

Heritage Global Inc.

Security class
Common Stock
Shares / value
47,968
Estimated value
$136,709
Report date
01 Sep 2021
Price
$2.85
Ownership
By spouse
Form 4 holding Executive Chairman, Director

POINT Biopharma Global Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
22 Dec 2023
Price
$12.45
Ownership
Anglian Holdings, LLC
Form 4 holding Executive Chairman, Director

POINT Biopharma Global Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
22 Dec 2023
Price
$12.45
Ownership
By Spouse
Form 4 holding Executive Chairman, Director

POINT Biopharma Global Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
22 Dec 2023
Price
$12.45
Ownership
Personal Holding Company
Form 4 holding Executive Chairman, Director

POINT Biopharma Global Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
22 Dec 2023
Price
$12.45
Ownership
Silber Holdings, Inc.
Form 4 holding Executive Chairman, Director

POINT Biopharma Global Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
27 Dec 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Allan C. Silber

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .